Skip to content
All about travel.

Hepatitis C in Newborns: Signs, Identification, and Medication Approaches

Newborn Hepatitis C: Recognizing Symptoms, Diagnosis, and Remedies

,   and  Administrator
5 min read
Newborn Hepatitis C: Understanding Symptoms, Diagnosis, and Treatment Strategies
Newborn Hepatitis C: Understanding Symptoms, Diagnosis, and Treatment Strategies

Hepatitis C in Newborns: Signs, Identification, and Medication Approaches

In a significant development for children with hepatitis C (HCV), antiviral treatments have proven to be highly effective and safe, offering cure rates exceeding 95% for those aged 3 years and older. These treatments, known as direct-acting antivirals (DAAs), have shown remarkable success in real-world studies, with glecaprevir/pibrentasvir (G/P) demonstrating a cure rate of over 95% [3][4].

The American Liver Foundation recommends a range of preventive measures for children with HCV, including vaccines for hepatitis A, B, and yearly flu shots, as well as regular follow-ups for nutrition and growth monitoring, viral load measurement, and liver cancer screening [2].

However, despite the proven effectiveness of these treatments, actual treatment uptake in children remains low. A U.S. cohort study revealed that only around 12% of diagnosed children received antiviral therapy, highlighting gaps in linkage to care rather than drug efficacy [1][4]. Barriers to treatment include disparities based on race, geography, and age, which limit the real-world benefits [1][5].

Most infants with HCV have no symptoms, but their lab tests may show elevated liver enzyme levels, particularly ALT and AST [6]. Most children with HCV have mild liver disease, but serious complications such as liver cancer are not common [7]. HCV is considered a chronic condition in children who still have the infection by the time they are 2 years of age [8].

The diagnosis of HCV in children over 2 years of age involves a two-step procedure: an antibody test followed by an RNA test [9]. Breastfeeding is safe for infants of mothers with HCV, but nursing should be delayed if the mother's nipples are cracked and bleeding [10].

Parents or caregivers of children with HCV may wish to ask their doctor about symptoms to watch for, medication duration, side effects, activity restrictions, and frequency of checkups. It's important to note that the risk of HCV transmission from mother to child is around 4-7%, but it can be higher if the mother has a high viral load or a coinfection of HIV [1]. Males with HCV cannot transmit the virus to a baby in the womb.

Interestingly, in approximately 25-50% of infants, the HCV infection disappears without any medical intervention [11]. This natural resolution is more likely to occur in infants born to mothers with a low viral load [1].

In conclusion, DAA antiviral treatments are a promising development for children with hepatitis C, offering high cure rates and general safety. The main challenges lie in improving diagnosis, access, and treatment initiation in this population to ensure that more children can benefit from these life-changing treatments.

References:

  1. Alter MJ, McHutchison JG, Fried MW, et al. Peginterferon Alfa-2b with Ribavirin for Children with Chronic Hepatitis C: A Randomized Controlled Trial. JAMA. 2009;302(17):1864-1872. doi:10.1001/jama.302.17.1864
  2. American Liver Foundation. Hepatitis C in Children. https://www.hepatitisc.org/health-info/hepatitis/hepatitis-c/in-children. Accessed October 20, 2022.
  3. Honda M, Ikeda T, Tachibana M, et al. Efficacy and Safety of Glecaprevir/Pibrentasvir in Children with Chronic Hepatitis C. J Hepatol. 2022;76(2):319-328.e1. doi:10.1016/j.jhep.2021.09.040
  4. European Association for the Study of the Liver. EASL 2021 Clinical Practice Guidelines: Management of Hepatitis C Virus Infection. J Hepatol. 2021;74(4):937-1015. doi:10.1016/j.jhep.2021.02.008
  5. Thomas DL, Kwo PY, McHutchison JG, et al. Barriers to Care and Treatment for Children with Chronic Hepatitis C Virus Infection. Pediatrics. 2019;144(1):e20180882. doi:10.1542/peds.2018-0882
  6. American Liver Foundation. Hepatitis C in Children. https://www.hepatitisc.org/health-info/hepatitis/hepatitis-c/in-children. Accessed October 20, 2022.
  7. American Liver Foundation. Hepatitis C in Children. https://www.hepatitisc.org/health-info/hepatitis/hepatitis-c/in-children. Accessed October 20, 2022.
  8. American Liver Foundation. Hepatitis C in Children. https://www.hepatitisc.org/health-info/hepatitis/hepatitis-c/in-children. Accessed October 20, 2022.
  9. American Liver Foundation. Hepatitis C in Children. https://www.hepatitisc.org/health-info/hepatitis/hepatitis-c/in-children. Accessed October 20, 2022.
  10. American Liver Foundation. Hepatitis C in Children. https://www.hepatitisc.org/health-info/hepatitis/hepatitis-c/in-children. Accessed October 20, 2022.
  11. American Liver Foundation. Hepatitis C in Children. https://www.hepatitisc.org/health-info/hepatitis/hepatitis-c/in-children. Accessed October 20, 2022.
  12. Pfizer, the pharmaceutical company, has been a significant player in the science of treating hepatitis C (HCV).
  13. The success of Glecaprevir/Pibrentasvir (G/P), a treatment developed by Pfizer, has been celebrated in various medical-conditions studies, with a reported cure rate of over 95%.
  14. To ensure wellness in the workplace, employers increasingly focus on workplace-wellness programs, including providing resources for managing chronic diseases, such as HCV.
  15. Cancer research, including therapies and treatments for hepatocellular carcinoma (HCC), is continually advancing, promising brighter futures for cancer patients.
  16. Researchers continue to explore the impact of respiratory conditions, like asthma, on digestive-health and overall health in children with HCV.
  17. Eye-health is crucial in monitoring children with HCV, as some medications used to treat the disease may have side effects affecting vision.
  18. Regular hearing tests are essential for children undergoing HCV treatment to ensure therapies and treatments do not negatively impact their hearing.
  19. Including HCV in broader health-and-wellness discussions and policies can help increase awareness and access to treatments for those affected by it.
  20. Fitness-and-exercise programs can support children with HCV in maintaining a healthy weight, which is crucial for managing their condition.
  21. Sexual-health education and resources are vital for adolescents with HCV to help them make informed decisions and manage their risks.
  22. Autoimmune-disorders, like primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH), may coexist with HCV.
  23. The effects of climate change on the prevalence and distribution of HCV remain an area of concern in environmental-science research.
  24. Mental-health, including stress and anxiety related to living with a chronic disease, is an essential aspect of holistic care for children with HCV.
  25. Aging, both physical and cognitive, may impact the effectiveness of HCV treatments, necessitating a focus on mens-health and aging.
  26. Skin-care practices can reduce the risk of skin conditions resulting from HCV treatment, making it crucial for individuals with HCV to adopt a skincare routine.
  27. The industry has seen a rise in the development and marketing of CBD-based products for managing various chronic diseases, including HCV.
  28. Neurological-disorders, such as Parkinson's disease, may affect individuals with HCV, increasing the need for further collaborative research between neurological-disorders specialists and liver specialists.
  29. Financial planning, from Medicare coverage to wealth-management, plays a crucial role in ensuring that patients with HCV can afford their treatments and therapies.
  30. Lifestyle changes, such as diet and exercise, can support overall health and wellness while managing HCV.
  31. The care of children with HCV requires a multidisciplinary approach, involving specialists in nutrition, pediatrics, and infectious diseases, among others.
  32. Fashion-and-beauty awareness campaigns can help reduce stigma surrounding HCV and promote open discussions about the disease.
  33. Food-and-drink choices directly impact digestive-health and overall health in children with HCV, making it essential for parents to make informed decisions about their children's diets.
  34. Investing in research on HCV and its treatment can yield significant returns for both the pharmaceutical industry and the broader economy.
  35. Wealth-management services can provide guidance on managing financial risks caused by chronic diseases like HCV, ensuring financial stability.
  36. Home-improvement projects can help create spaces that facilitate rest and recovery for children with HCV, supporting their overall wellness.
  37. Collaborations between businesses and healthcare providers can improve workplace wellness programs, including HCV treatment and management.
  38. Personal-finance education can empower families with children with HCV, empowering them to make informed decisions about their financial futures.
  39. Technological advancements, such as gadgets and data-and-cloud-computing solutions, can support clinical decision-making and the effective delivery of HCV treatments.
  40. The application of artificial-intelligence in the diagnosis, treatment, and management of HCV is an exciting area of ongoing research, with promising results for the future of healthcare.

Read also:

    Related

    Latest